Clinical Trials

Showing 161 - 180 of 509 trials
Titlesort icon Investigator Disease(s)
A Phase Ib Study of ARN-509 plus Everolimus in Men with Progressive Metastatic Castration-Resistant Prostate Cancer After Abiraterone Therapy
[Protocol 13-025]
Rathkopf, Dana
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase Ib Study of AZD9291 as Part of Combination Therapy in Patients with Non-Small Cell Lung Cancer which Has Continued to Grow Despite EGFR-Targeting Therapy
[Protocol 14-161]
Yu, Helena
  • Lung Cancer, Non-Small Cell
A Phase IB Study of BGJ398 plus Imatinib in Patients with Persistent Gastrointestinal Stromal Tumor
[Protocol 14-140]
Tap, William
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase IB Study of BYL719 plus Everolimus in Patients with Advanced Cancers
[Protocol 14-097]
Fury, Matthew
  • Solid Tumors
A Phase IB Study of Dalantercept plus Sorafenib in Patients with Advanced Liver Cancer
[Protocol 14-092]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase IB Study of GDC-0199 (ABT-199 or Venetoclax) with R-CHOP or G-CHOP in Patients with B-Cell Non-Hodgkin Lymphoma
[Protocol 14-130]
Zelenetz, Andrew
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase IB Study of GSK3052230 with Chemotherapy in Patients with Metastatic Squamous Cell Lung Cancer or Advanced Pleural Mesothelioma
[Protocol 13-256]
Paik, Paul
  • Lung Cancer, Non-Small Cell
    • Other
  • Mesothelioma
A Phase IB Study of INC280 plus Cetuximab in Patients with Recurrent or Metastatic Colorectal or Head and Neck Cancer
[Protocol 14-173]
Fury, Matthew
  • Colorectal Cancer
  • Head & Neck Cancer
A Phase IB Study of LEE011 and Exemestane with and without Everolimus in Women with Locally Advanced or Metastatic Breast Cancer
[Protocol 13-179]
Modi, Shanu
  • Breast Cancer
A Phase IB Study of LY2835219 plus Hormonal Therapy in Women with Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
[Protocol 14-085]
Dickler, Maura
  • Breast Cancer
A Phase IB Study of MEK162 plus Paclitaxel in Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-192]
Grisham, Rachel
  • Ovarian Cancer
A Phase IB Study of MK-3475 in Patients with Myelodysplastic Syndromes and Lymphoma
Relapsed/Refractory
[Protocol 13-220]
Moskowitz, Craig
  • Hematology
    • Myelodysplastic Syndrome
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase IB Study of MPDL3280A and Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 14-020]
Rudin, Charles
A Phase IB Study of MPDL3280A plus Cobimetinib in Patients with Locally Advanced or Metastatic Solid Tumors
[Protocol 13-223]
Hellmann, Matthew
  • Solid Tumors
A Phase Ib Study of OMP-54F28 with Paclitaxel and Carboplatin in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
[Protocol 14-029]
O'Cearbhaill, Roisin
  • Ovarian Cancer
A Phase Ib Study of Oral BGJ398 and BYL719 in Patients with Certain Advanced Solid Tumors
[Protocol 13-246]
Fury, Matthew
  • Breast Cancer
  • Solid Tumors
A Phase Ib Study of Ramucirumab plus LY2875358 in Patients with Advanced Cancer
[Protocol 14-049]
Harding, James
  • Solid Tumors
A Phase IB Study of SAR650984 with Lenalidomide and Dexamethasone to Treat Recurrent or Persistent Multiple Myeloma
[Protocol 13-006]
Lendvai, Nikoletta
  • Hematology
    • Multiple Myeloma
A Phase Ib Study of Tremelimumab and MEDI4736 in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 13-197]
Rizvi, Naiyer
  • Lung Cancer, Non-Small Cell
A Phase IB Study of Urelumab (BMS-663513) plus Cetuximab in Patients with Persistent Head and Neck or Colorectal Cancer
[Protocol 14-121]
Segal, Neil
  • Colorectal Cancer
  • Head & Neck Cancer